The prevalence of MS but not neuromyelitis optica (NMO), an autoimmune astrocytopathy induced by anti-aquaporin-4 (AQP4) antibody, has increased in Japan over the last 30 years [32]. The gene discussed is AQP4; the disease is neuromyelitis optica.